United States - X-Ray Diffraction (XRD) Instrument

For more information and to make a bid you will need to go to the third party website.


Provided by Open Opps
Opportunity closing date
14 August 2019
Opportunity publication date
08 August 2019
Value of contract
to be confirmed
Your guide to exporting
Report opportunity


Added: Aug 07, 2019 1:02 pm

The U.S. Food and Drug Administration's Center for Drug Evaluation (CDER), Division of Pharmaceutical Analysis has a requirement for to acquire XRD systems to perform testing and research on characterizing opioid drug products and other pharmaceuticals.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a separate written solicitation will not be issued.
This solicitation is a Request for Quote (RFQ) using FAR Parts 12 and 13.5 procedures. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-03. The North American Industry Classification System (NAICS) code for the proposed acquisition is 334516, Analytical Laboratory Instrument Manufacturing.
For full description/details please refer to attached document "FDA-19-RFQ-1214636.pdf"

Opportunity closing date
14 August 2019
Value of contract
to be confirmed

About the buyer

Department of Health and Human Services Office of Acquisitions and Grants Services - Rockville United States

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?